Mycobacterium Tuberculosis—Associated Immune Reconstitution Syndrome in Solid-Organ Transplant Recipients
Authors:
- Hsin-Yun SunHSHsin-Yun Sun
- Patricia MunozPMPatricia Munoz
- Julian Torre-CisnerosJTJulian Torre-Cisneros
- Jose M. AguadoJAJose M. Aguado
- Roberta LattesRLRoberta Lattes
- Miguel MontejoMMMiguel Montejo
- Ana Garcia-ReyneAGAna Garcia-Reyne
- Emilio BouzaEBEmilio Bouza
- Maricela ValerioMVMaricela Valerio
- Rosario LaraRLRosario Lara
- George T. JohnGJGeorge T. John
- Didier BrunoDBDidier Bruno
- 15 May 2013
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 95 (9) , 1173-1181
Abstract
Incidence, characteristics, and risk factors for tuberculosis (TB)-associated immune reconstitution inflammatory syndrome (IRS) in solid-organ transplant (SOT) recipients are not known. Patients are composed of 64 consecutive SOT recipients with TB followed for 12 months. IRS was defined based on previously proposed criteria. IRS developed in 14% (9/64) of the patients, a median of 47 days after the use of anti-TB therapy. Liver versus other types of organ transplant recipients (adjusted odds ratio [OR], 6.11; 95% confidence interval [CI], 1.08–34.86), prior cytomegalovirus infection (adjusted OR, 5.65; 95% CI, 0.93–34.47), and rifampin use (adjusted OR, 4.56; 95% CI, 0.74–27) were associated with a higher risk of IRS. The presence of more than one factor (liver transplantation, cytomegalovirus infection, and rifampin use) when compared with none of these factors conferred a 19-fold increase in the risk of IRS (P=0.01). Mortality at 1 year after diagnosis was 33.3% in patients with IRS and 17.2% in those without IRS (P=0.31). IRS was documented in 14% of the SOT recipients with TB. We determined clinically identifiable factors that may be useful in assessing the risk of tuberculosis-associated posttransplantation IRS.Keywords
This publication has 29 references indexed in Scilit:
- Immune reconstitution syndrome and fungal infectionsCurrent Opinion in Infectious Diseases, 2011
- Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial LoadThe Journal of Immunology, 2011
- Opportunistic Infection-Associated Immune Reconstitution Syndrome in Transplant RecipientsClinical Infectious Diseases, 2011
- Macrophages and control of granulomatous inflammation in tuberculosisMucosal Immunology, 2011
- Tuberculosis after Solid‐Organ Transplant: Incidence, Risk Factors, and Clinical Characteristics in the RESITRA (Spanish Network of Infection in Transplantation) CohortClinical Infectious Diseases, 2009
- Antimicrobial and Immunomodulatory Attributes of Statins: Relevance in Solid‐Organ Transplant RecipientsClinical Infectious Diseases, 2009
- Mycobacterium tuberculosis Infection in Recipients of Solid Organ TransplantsClinical Infectious Diseases, 2005
- Control of human host immunity to mycobacteriaTuberculosis, 2005
- Immune responses in tuberculosisCurrent Opinion in Immunology, 2000
- Mycobacterium tuberculosisInfection in Solid‐Organ Transplant Recipients: Impact and Implications for ManagementClinical Infectious Diseases, 1998